COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

[1]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[2]  D. Archer,et al.  The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection , 2020, Frontiers in Medicine.

[3]  Kwok-Hung Chan,et al.  Consistent Detection of 2019 Novel Coronavirus in Saliva , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Ching-lung Lai,et al.  SARS‐associated viral hepatitis caused by a novel coronavirus: Report of three cases , 2004, Hepatology.

[5]  Qiang Huang,et al.  Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV) , 2020, bioRxiv.

[6]  T. Şahin,et al.  COVID-19 pandemic: Its impact on liver disease and liver transplantation , 2020, World journal of gastroenterology.

[7]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[8]  A. Basson,et al.  Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease , 2020, Translational Research.

[9]  J. Sung,et al.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection , 2003 .

[10]  M. Gordon,et al.  Rapid systematic review of neonatal COVID-19 including a case of presumed vertical transmission , 2020, BMJ paediatrics open.

[11]  Jue Fan,et al.  Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection , 2020, bioRxiv.

[12]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[13]  Huji Xu,et al.  The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes , 2020, bioRxiv.

[14]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.